ABT|Abbott Laboratories|가격:110.830|Chg%:1.76

자세한 내용은 Abbott Laboratories 회사

Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.

Abbott Laboratories 정보



종목 코드 ABT

회사 이름Abbott Laboratories

상장일Apr 06, 2073

CEOFord (Robert B)

직원 수114000

유형Ordinary Share

회계 연도 종료Apr 06

주소100 Abbott Park Road

도시ABBOTT PARK

증권 거래소NASDAQ OMX NASDAQ Basic NYSE

국가United States of America

우편 번호60064-3500

전화12246676100

웹사이트https://www.abbott.com

종목 코드 ABT

상장일Apr 06, 2073

CEOFord (Robert B)

Abbott Laboratories의 회사 임원진



이름

이름/직위

직위

주식 보유

변동

Mr. Daniel J. Starks

Independent Director

6.74M

+10000.00%

Mr. Daniel Gesua Sive Salvadori

Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products

132.23K

-1536.00%

Ms. Mary K. Moreland

Executive Vice President - Human Resources

95.58K

-791.00%

Ms. Lisa D. Earnhardt

Executive Vice President, Group President - Medical Devices

71.93K

--

Mr. Louis H. (Lou) Morrone

Executive Vice President - Core Diagnostics

66.61K

-269.00%

Mr. Philip P. Boudreau

Chief Financial Officer, Executive Vice President - Finance

50.97K

-387.00%

Dr. Robert J. Alpern, M.D.

Independent Director

40.80K

+1635.00%

Ms. Sally E. Blount, Ph.D.

Independent Director

34.06K

-965.00%

Mr. John G. Stratton

Independent Director

19.03K

+1635.00%

Ms. Michelle A. Kumbier

Independent Director

15.71K

+1635.00%

이름

이름/직위

직위

주식 보유

변동

Mr. Daniel J. Starks

Independent Director

6.74M

+10000.00%

Mr. Daniel Gesua Sive Salvadori

Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products

132.23K

-1536.00%

Ms. Mary K. Moreland

Executive Vice President - Human Resources

95.58K

-791.00%

Ms. Lisa D. Earnhardt

Executive Vice President, Group President - Medical Devices

71.93K

--

Mr. Louis H. (Lou) Morrone

Executive Vice President - Core Diagnostics

66.61K

-269.00%

Mr. Philip P. Boudreau

Chief Financial Officer, Executive Vice President - Finance

50.97K

-387.00%

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

사업별USD

이름

수익

비율

Diabetes Care

2.06B

18.09%

Core Laboratory

1.36B

12.00%

Structural Heart

1.28B

11.23%

Adult Nutritionals

1.18B

10.34%

Key Emerging Markets

1.10B

9.65%

기타

4.40B

38.68%

지역별USD

이름

수익

비율

All other Countries

7.07B

62.19%

United States

4.30B

37.81%

사업별

지역별

사업별USD

이름

수익

비율

Diabetes Care

2.06B

18.09%

Core Laboratory

1.36B

12.00%

Structural Heart

1.28B

11.23%

Adult Nutritionals

1.18B

10.34%

Key Emerging Markets

1.10B

9.65%

기타

4.40B

38.68%

주식 보유 통계

마지막 업데이트: Mon, Nov 17

주주

주주 유형

주주

비율

The Vanguard Group, Inc.

10.05%

BlackRock Institutional Trust Company, N.A.

5.13%

State Street Investment Management (US)

4.50%

Capital International Investors

3.54%

Capital Research Global Investors

2.23%

기타

74.55%

주주

비율

The Vanguard Group, Inc.

10.05%

BlackRock Institutional Trust Company, N.A.

5.13%

State Street Investment Management (US)

4.50%

Capital International Investors

3.54%

Capital Research Global Investors

2.23%

기타

74.55%

주주 유형

주주

비율

Investment Advisor

47.28%

Investment Advisor/Hedge Fund

23.20%

Research Firm

3.50%

Pension Fund

2.39%

Bank and Trust

2.21%

Sovereign Wealth Fund

1.37%

Insurance Company

1.02%

Hedge Fund

0.49%

Individual Investor

0.48%

기타

18.07%

기관 주식 보유



마지막 업데이트: Mon, Dec 8

보고 기간

기관 수

보유 주식

비율

변동

2025Q4

4606

1.42B

81.82%

+3.92M

2025Q3

4681

1.42B

81.87%

+8.53M

2025Q2

4668

1.41B

81.51%

+6.23M

2025Q1

4636

1.40B

80.10%

+7.18M

2024Q4

4554

1.38B

78.81%

+33.68M

2024Q3

4367

1.35B

78.83%

-5.95M

2024Q2

4376

1.35B

78.36%

+5.03M

2024Q1

4375

1.35B

77.56%

-1.86M

2023Q4

4400

1.34B

77.62%

+7.10M

2023Q3

4258

1.33B

78.26%

-4.16M

주주 활동



이름

보유 주식

비율

변동

Chg %

날짜

The Vanguard Group, Inc.

174.89M

10.06%

+2.54M

+1.47%

Nov 28, 2025

BlackRock Institutional Trust Company, N.A.

89.23M

5.13%

+711.43K

+0.80%

Sep 30, 2025

State Street Investment Management (US)

78.23M

4.5%

-128.28K

-0.16%

Sep 30, 2025

Capital International Investors

61.61M

3.54%

+1.48M

+2.46%

Sep 30, 2025

Capital Research Global Investors

38.77M

2.23%

-3.00M

-7.18%

Sep 30, 2025

Geode Capital Management, L.L.C.

38.54M

2.22%

+248.83K

+0.65%

Sep 30, 2025

Wellington Management Company, LLP

23.25M

1.34%

-1.80M

-7.20%

Sep 30, 2025

Norges Bank Investment Management (NBIM)

22.25M

1.28%

+1.27M

+6.03%

Jun 30, 2025

JP Morgan Asset Management

19.25M

1.11%

-7.14M

-27.05%

Sep 30, 2025

T. Rowe Price Investment Management, Inc.

17.77M

1.02%

+9.40M

+112.38%

Sep 30, 2025

주식 배당금



지난 5년 동안 총 13.90B USD의 배당금이 분배되었습니다.

날짜

배당금

기준일

지급일

배당락일

Dec 12, 2025

ABT.NB Final Cash Dividend of gross USD 0.63 paid on Feb 13, 2026 going ex on Jan 15, 2026 with reinvestment option

Jan 15, 2026

Feb 13, 2026

Jan 15, 2026

Sep 19, 2025

ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Nov 17, 2025 going ex on Oct 15, 2025 with reinvestment option

Oct 15, 2025

Nov 17, 2025

Oct 15, 2025

Jun 13, 2025

ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Aug 15, 2025 going ex on Jul 15, 2025 with reinvestment option

Jul 15, 2025

Aug 15, 2025

Jul 15, 2025

Feb 21, 2025

ABT.NB Interim Cash Dividend of gross USD 0.59 paid on May 15, 2025 going ex on Apr 15, 2025 with reinvestment option

Apr 15, 2025

May 15, 2025

Apr 15, 2025

Dec 13, 2024

ABT.NB Final Cash Dividend of gross USD 0.59 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option

Jan 15, 2025

Feb 14, 2025

Jan 15, 2025

Sep 19, 2024

ABT.NB Final Cash Dividend of gross USD 0.55 paid on Nov 15, 2024 going ex on Oct 15, 2024

Oct 15, 2024

Nov 15, 2024

Oct 15, 2024

Jun 15, 2024

ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option

Jul 15, 2024

Aug 15, 2024

Jul 15, 2024

Feb 16, 2024

ABT.NB Interim Cash Dividend of gross USD 0.55 paid on May 15, 2024 going ex on Apr 12, 2024

Apr 15, 2024

May 15, 2024

Apr 12, 2024

Dec 15, 2023

ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Feb 15, 2024 going ex on Jan 11, 2024 with reinvestment option

Jan 12, 2024

Feb 15, 2024

Jan 11, 2024

Sep 21, 2023

ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Nov 15, 2023 going ex on Oct 12, 2023 with reinvestment option

Oct 13, 2023

Nov 15, 2023

Oct 12, 2023

주식 분할



날짜

배당락일

유형

비율

데이터 없음

날짜

배당락일

유형

비율

데이터 없음

Abbott Laboratories

자세한 내용은 Abbott Laboratories 회사

Abbott Laboratories 정보

Abbott Laboratories의 회사 임원진

수익 분석

주식 보유 통계

기관 주식 보유

주주 활동

관련 ETF

주식 배당금

주식 분할